BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 33569762)

  • 1. Association of Unrecognized Myocardial Infarction With Long-term Outcomes in Community-Dwelling Older Adults: The ICELAND MI Study.
    Acharya T; Aspelund T; Jonasson TF; Schelbert EB; Cao JJ; Sathya B; Dyke CK; Aletras AH; Sigurdsson S; Thorgeirsson G; Eiriksdottir G; Harris T; Launer LJ; Gudnason V; Arai AE
    JAMA Cardiol; 2018 Nov; 3(11):1101-1106. PubMed ID: 30304454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum copeptin and cortisol do not accurately predict sickle cell anaemia vaso-occlusive crisis as C-reactive protein.
    Akinlade KS; Atere AD; Olaniyi JA; Rahamon SK; Adewale CO
    PLoS One; 2013; 8(11):e77913. PubMed ID: 24223742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyzing the Release of Copeptin from the Heart in Acute Myocardial Infarction Using a Transcoronary Gradient Model.
    Boeckel JN; Oppermann J; Anadol R; Fichtlscherer S; Zeiher AM; Keller T
    Sci Rep; 2016 Feb; 6():20812. PubMed ID: 26864512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a New Aptamer-Based Array for Soluble Suppressor of Tumorgenicity (ST2) and N-terminal Pro-B-Type Natriuretic Peptide (NTproBNP) in Heart Failure Patients.
    Debbs J; Hannawi B; Peterson E; Gui H; Zeld N; Luzum JA; Sabbah HN; Snider J; Pinto YM; Williams LK; Lanfear DE
    J Cardiovasc Transl Res; 2023 Dec; 16(6):1343-1348. PubMed ID: 37191882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate infusion associated with reduced rises of p-Copeptin after coronary surgery: Substudy of GLUTAMICS II.
    Svedjeholm R; Ferrari G; Vanky F; Friberg Ö; Holm J
    Acta Anaesthesiol Scand; 2023 Nov; 67(10):1373-1382. PubMed ID: 37365871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High level of psychological stress in COVID-19 recovered individuals: role of copeptin as a potential biomarker.
    Nonglait PL; Madhu SV; Raizada N; Aggarwal A; Ahmed R; Aslam M
    Front Psychol; 2023; 14():1253396. PubMed ID: 38155695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of oral anticoagulants in everyday practice.
    Camm AJ; Fox KAA; Virdone S; Bassand JP; Fitzmaurice DA; Berchuck SI; Gersh BJ; Goldhaber SZ; Goto S; Haas S; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Cappato R; Kakkar AK;
    Heart; 2021 May; 107(12):962-970. PubMed ID: 33593994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body volume is the major determinant of worsening renal function in acutely decompensated heart failure with reduced left ventricular ejection fraction.
    Ho MH; Huang D; Ho CW; Zuo ML; Luo AG; Cheung E; Zhou M; Cheng Y; Liu M; Yiu KH; Lau CP; Yeung P; Yue WS; Yin LX; Tse HF; Jiang W; Lei Z; Li XL; Cowie M; Siu CW
    Postgrad Med J; 2022 May; 98(1159):333-340. PubMed ID: 33593808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of primary percutaneous coronary intervention on in-hospital outcomes among active cancer patients presenting with ST-elevation myocardial infarction: a propensity score matching analysis.
    Mohamed MO; Van Spall HGC; Kontopantelis E; Alkhouli M; Barac A; Elgendy IY; Khan SU; Kwok CS; Shoaib A; Bhatt DL; Mamas MA
    Eur Heart J Acute Cardiovasc Care; 2021 Oct; 10(8):829-839. PubMed ID: 33587752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial.
    Zelniker TA; Ardissino M; Andreotti F; O'Donoghue ML; Yin O; Park JG; Murphy SA; Ruff CT; Lanz HJ; Antman EM; Braunwald E; Giugliano RP; Merlini PA
    Circulation; 2021 Feb; 143(7):673-684. PubMed ID: 33587659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a Coordinated Community and Chronic Care Model Team Intervention vs Usual Care on Systolic Blood Pressure in Patients With Stroke or Transient Ischemic Attack: The SUCCEED Randomized Clinical Trial.
    Towfighi A; Cheng EM; Ayala-Rivera M; Barry F; McCreath H; Ganz DA; Lee ML; Sanossian N; Mehta B; Dutta T; Razmara A; Bryg R; Song SS; Willis P; Wu S; Ramirez M; Richards A; Jackson N; Wacksman J; Mittman B; Tran J; Johnson RR; Ediss C; Sivers-Teixeira T; Shaby B; Montoya AL; Corrales M; Mojarro-Huang E; Castro M; Gomez P; Muñoz C; Garcia D; Moreno L; Fernandez M; Lopez E; Valdez S; Haber HR; Hill VA; Rao NM; Martinez B; Hudson L; Valle NP; Vickrey BG;
    JAMA Netw Open; 2021 Feb; 4(2):e2036227. PubMed ID: 33587132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient factors associated with titration of medical therapy in patients with heart failure with reduced ejection fraction: data from the QUALIFY international registry.
    Cowie MR; Schöpe J; Wagenpfeil S; Tavazzi L; Böhm M; Ponikowski P; Anker SD; Filippatos GS; Komajda M;
    ESC Heart Fail; 2021 Apr; 8(2):861-871. PubMed ID: 33569926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome.
    Katsioupa M; Kourampi I; Oikonomou E; Tsigkou V; Theofilis P; Charalambous G; Marinos G; Gialamas I; Zisimos K; Anastasiou A; Katsianos E; Kalogeras K; Katsarou O; Vavuranakis M; Siasos G; Tousoulis D
    Life (Basel); 2023 Sep; 13(10):. PubMed ID: 37895374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitivity troponin I with or without ultra-sensitive copeptin for the instant rule-out of acute myocardial infarction.
    Ricci F; Neumann JT; Rübsamen N; Sörensen NA; Ojeda F; Cataldo I; Zeller T; Schäfer S; Hartikainen TS; Golato M; Palermi S; Zimarino M; Blankenberg S; Westermann D; De Caterina R
    Front Cardiovasc Med; 2022; 9():895421. PubMed ID: 36017085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction.
    Stătescu C; Anghel L; Tudurachi BS; Leonte A; Benchea LC; Sascău RA
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases.
    Mu D; Cheng J; Qiu L; Cheng X
    Front Cardiovasc Med; 2022; 9():901990. PubMed ID: 35859595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Copeptin for Early Diagnosis of Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of 14,139 Patients.
    Szarpak L; Lapinski M; Gasecka A; Pruc M; Drela WL; Koda M; Denegri A; Peacock FW; Jaguszewski MJ; Filipiak KJ
    J Cardiovasc Dev Dis; 2021 Dec; 9(1):. PubMed ID: 35050216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copeptin is associated with mortality in elderly people.
    Smaradottir MI; Andersen K; Gudnason V; Näsman P; Rydén L; Mellbin LG
    Eur J Clin Invest; 2021 Jul; 51(7):e13516. PubMed ID: 33569762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.
    Khan SQ; Dhillon OS; O'Brien RJ; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
    Circulation; 2007 Apr; 115(16):2103-10. PubMed ID: 17420344
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.